Raisio is entering the new growth construction phase FINANCIAL DEVELOPMENT IN BRIEF
January-
- The Group's net sales totalled
EUR 50.0 (54.7) million, which signified a decrease of -8.7%. -
Comparable EBIT was
EUR 4.7 (6.6) million, which signified a decrease of -29.0%. That accounted for 9.4 (12.0)% of net sales. -
EBIT was
EUR 7.5 * (6.6) million, which accounted for 15.0 (12.0)% of net sales. -
The Healthy Food Segment's net sales totalled
EUR 34.4 (37.3) million. EBIT wasEUR 4.8 (5.3) million, which accounted for 14.1 (14.2)% of net sales. -
The Healthy Ingredients Segment's net sales totalled
EUR 22.3 (25.6) million. Comparable EBIT wasEUR 0.7 (2.2) million, which accounted for 3.0 (8.6)% of net sales. EBIT wasEUR 3.5 (2.2) million, which accounted for 15.5 (8.6)% of net sales. -
The Group's cash flow from business operations after financial items and taxes totalled
EUR 3.2 (3.9) million. - The comparable return on investments (ROIC) was 6.3 (4.4)% and the return on investments (ROIC) was 11.6 (4.4)%.
-
The overall effect of currency conversions was
EUR -1.0 (0.3) million on net sales,EUR -0.1 (0.1) million on the comparable EBIT andEUR -0.1 (0.1) million on EBIT.
*EBIT includes
OUTLOOK 2021
Raisio's guidelines: In 2021, Raisio estimates that net sales will increase (net sales in 2020:
KEY FIGURES OF THE GROUP
1-3/2021 | 1-3/2020 | 1-12/2020 | ||
Net sales | ME | 50.0 | 54.7 | 233.6 |
Change in net sales | % | -8.7 | 9.7 | -1.2 |
Comparable EBITDA | ME | 6.2 | 8.1 | 33.9 |
EBITDA | ME | 9.0 | 8.1 | 35.1 |
Comparable EBIT | ME | 4.7 | 6.6 | 27.7 |
Comparable EBIT of net sales | % | 9.4 | 12.0 | 11.9 |
EBIT | ME | 7.5 | 6.6 | 28.9 |
EBIT of net sales | % | 15.0 | 12.0 | 12.4 |
Comparable earnings per share | E | 0.02 | 0.01 | 0.14 |
Earnings per share | E | 0.04 | 0.01 | 0.15 |
PRESIDENT AND CEO PEKKA KUUSNIEMI:
They say that no two years are alike and that description is accurate when we compare Raisio Group's first quarter of 2021 with the same period one year earlier. One year ago, the pandemic caused a completely exceptional barrage of demand that strongly drove up sales in all of Raisio's consumer markets. The other distinctive factor is the later-than-usual start of Raisioaqua's 2021 season due to a winter season that extended longer than during the previous year. For the aforementioned reasons, net sales and profitability declined when viewed against the highly exceptional comparison period.
The Group's net sales totalled
The
Our investments clearly reflect Raisio's long-term strategy, in which plant-based added-value products have been the focus for the past two years. The investments for the first quarter totalled
During this review period, we prepared for a corporate acquisition that was especially well-suited to our strategy. The acquisition was announced immediately at the start of the new quarter. Raisio acquired
The ongoing exceptional situation has naturally also tried the coping abilities of our personnel. Despite this, we have managed to work without disruption and to deliver our products on time. I would like to thank the entire personnel of Raisio for its fine work and patience during this challenging time. I would also like to warmly welcome into the service of our company all those new Raisio employees who have joined us by virtue of the corporate acquisition.
In Raisio,
Board of Directors
Further information:
Pekka Kuusniemi, President and CEO, tel. +358 50 537 3883
The information in this Interim Report is unaudited.
Raisio will hold a Capital Market Day on
Raisio is an international company specialized in healthy, responsibly produced food, ingredients and fish feeds. Our well-known brands include, for example, Benecol®, Beanit®, Elovena®, Sunnuntai®, Torino® and Benella®. In Raisio's products, the focus is on well-being, health, good taste and sustainable development. Profitable growth is ensured through our strong expertise and passion for creating new. Raisio's shares are listed on
https://news.cision.com/raisio-oyj/r/raisio-plc-s-interim-report-january-march-2021,c3340344
https://mb.cision.com/Main/19289/3340344/1412744.pdf
(c) 2021 Cision. All rights reserved., source